REG - Braveheart Inv Group - Completion of sale of Phasefocus

Braveheart InvestmentAnnouncement

04/03/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240304:nRSD3628Fa&default-theme=true

RNS Number : 3628F  Braveheart Investment Group plc  04 March 2024

4 March 2024

 

Braveheart Investment Group Plc

("Braveheart", the "Company" or the "Group")

 

Completion of sale of Phasefocus

 

Braveheart Investment Group (AIM: BRH), is pleased to announce that, further
to the announcement on 22 December 2023 regarding the sale of Phasefocus
Holdings Limited ("Phasefocus") to Bruker UK Limited, all outstanding
conditions to the sale have now been satisfied and the sale has therefore
completed.  The total proceeds receivable by the Company for the Sale was
approximately £2.1 million (after expenses).

 

Trevor Brown, CEO of Braveheart, commented: "The sale of our holding in
Phasefocus represents a gain of £1.31m over cost, which is a highly
satisfactory CAGR of 48.29% for Braveheart shareholders."

 

For further information:

 

 Braveheart Investment Group plc                                Tel: 01738 587555
 Trevor Brown, Chief Executive Officer

 Viv Hallam, Executive Director
 Allenby Capital Limited (Nominated Adviser and Joint Broker)   Tel: 020 3328 5656
 James Reeve / George Payne

 Peterhouse Capital Limited (Joint Broker)                      Tel: 020 7469 0936
 Duncan Vasey / Lucy Williams

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DISQKNBPBBKDBNK